Abstract
Background and objectives Acute kidney injury after surgery is associated with high mortality and morbidity. The purpose of this study is to develop and validate a risk prediction tool for the occurrence of postoperative acute kidney injury requiring renal replacement therapy.
Design, setting, participants, measurements This retrospective cohort study had 2,299,502 surgical patients over 2015-2017 from the American College of Surgeons National Surgical Quality Improvement Program Database (ACS-NSQIP). Eleven predictors were selected for the predictive model: age, history of congestive heart failure, diabetes, ascites, emergency surgery, preoperative serum creatinine, hematocrit, sodium, preoperative sepsis, preoperative acute renal failure and surgery type. The predictive model was trained using 2015-2016 data (n=1,487,724) and further tested using 2017 data (n=811,778). A risk model was developed using multivariate logistic regression and machine learning methods.
Main outcomes The primary outcome was postoperative 30-day acute kidney injury requiring renal replacement therapy(AKI-D)
Results The unadjusted 30-day postoperative mortality rate associated with AKI-D was 37.5%. The renal risk prediction model had high AUC (area under the receiver operating characteristic curve, training cohort: 0.89, test cohort: 0.90) for postoperative AKI-D.
Conclusions This model provides a clinically useful bedside predictive tool for postoperative acute kidney injury requiring dialysis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was obtained for this manuscript
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Thomas Jefferson University Institutional Review Board and informed consents were waived.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is available at American College of Surgeons (ACS-NSQIP).
